| Key Financial Ratios of JB Chemicals and Pharmaceuticals (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
33.70 |
22.15 |
15.24 |
20.39 |
21.09 |
|
| Diluted EPS (Rs.) |
33.70 |
22.15 |
15.24 |
20.39 |
21.09 |
|
| Cash EPS (Rs.) |
43.12 |
29.52 |
22.01 |
25.85 |
25.89 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
187.02 |
185.02 |
173.91 |
163.62 |
144.15 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
187.02 |
185.02 |
173.91 |
163.62 |
144.15 |
|
| Dividend / Share(Rs.) |
11.00 |
5.00 |
2.00 |
1.00 |
5.00 |
|
| Revenue from Operations/Share (Rs.) |
212.31 |
187.10 |
150.14 |
141.32 |
134.84 |
|
| PBDIT/Share (Rs.) |
54.03 |
40.91 |
28.53 |
31.60 |
33.18 |
|
| PBIT/Share (Rs.) |
45.61 |
34.07 |
21.83 |
26.15 |
28.41 |
|
| PBT/Share (Rs.) |
43.94 |
33.56 |
21.42 |
25.56 |
27.20 |
|
| Net Profit/Share (Rs.) |
34.70 |
22.69 |
15.32 |
20.39 |
21.13 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
25.45 |
21.86 |
19.00 |
22.36 |
24.60 |
|
| PBIT Margin (%) |
21.48 |
18.21 |
14.54 |
18.50 |
21.07 |
|
| PBT Margin (%) |
20.69 |
17.93 |
14.26 |
18.08 |
20.17 |
|
| Net Profit Margin (%) |
16.34 |
12.12 |
10.20 |
14.42 |
15.66 |
|
| Return on Networth / Equity (%) |
18.55 |
12.26 |
8.80 |
12.46 |
14.65 |
|
| Return on Capital Employed (%) |
23.21 |
17.48 |
12.03 |
15.51 |
14.12 |
|
| Return on Assets (%) |
14.80 |
10.15 |
7.24 |
10.26 |
10.91 |
|
| Total Debt/Equity (X) |
0.02 |
0.02 |
0.02 |
0.04 |
0.14 |
|
| Asset Turnover Ratio (%) |
90.59 |
83.76 |
71.02 |
71.16 |
69.68 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.44 |
4.32 |
3.94 |
2.92 |
2.01 |
|
| Quick Ratio (X) |
2.64 |
3.41 |
3.23 |
2.29 |
1.65 |
|
| Inventory Turnover Ratio (X) |
7.07 |
7.21 |
7.14 |
7.49 |
8.58 |
|
| Dividend Payout Ratio (NP) (%) |
52.78 |
11.06 |
7.85 |
2.95 |
105.38 |
|
| Dividend Payout Ratio (CP) (%) |
42.47 |
8.50 |
5.46 |
2.32 |
85.99 |
|
| Earnings Retention Ratio (%) |
47.22 |
88.94 |
92.15 |
97.05 |
-5.38 |
|
| Cash Earnings Retention Ratio (%) |
57.53 |
91.50 |
94.54 |
97.68 |
14.01 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
3,949.10 |
2,890.33 |
2,597.51 |
2,984.92 |
2,279.11 |
|
| EV/Net Operating Revenue (X) |
2.41 |
1.93 |
2.07 |
2.49 |
1.99 |
|
| EV/EBITDA (X) |
9.46 |
8.81 |
10.90 |
11.14 |
8.10 |
|
| MarketCap/Net Operating Revenue (X) |
2.39 |
1.92 |
2.06 |
2.46 |
1.85 |
|
| Retention Ratios (%) |
47.21 |
88.93 |
92.14 |
97.04 |
-5.38 |
|
| Price/BV (X) |
2.72 |
1.94 |
1.78 |
2.12 |
1.73 |
|
| Price/Net Operating Revenue |
2.39 |
1.92 |
2.06 |
2.46 |
1.85 |
|
| Earnings Yield |
0.07 |
0.06 |
0.05 |
0.06 |
0.08 |
|
Source : Dion Global Solutions Limited
